Human Immunology Project Consortium (HIPC) (U19 Clinical Trial Optional)

Human Immunology Project Consortium (HIPC) (U19 Clinical Trial Optional)

UA may submit 1 application.

This Funding Opportunity Announcement (FOA) for the Human Immunology Project Consortium (HIPC) solicits applications from single institutions, or consortia of institutions, to participate in a network of human immunology profiling research groups in the area of infectious diseases, including HIV. The purpose of this FOA is to characterize human immune responses/mechanisms elicited by vaccinations, vaccine adjuvants or natural infections by capitalizing on recent advances in immune profiling technologies.

No applicants.

Funding Type
Internal Deadline
External Deadline
06/04/2021
Solicitation Type

Subscribe to the UArizona Impact in Action newsletter to receive featured stories and event info to connect you with UArizona's research, innovation, entrepreneurial ventures, and societal impacts.

Subscribe now